AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

JW Pharmaceutical Corporation

₩22350 -$6250.00 (-21.85%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩22400
Day Range
₩22200₩22350
Year Range
₩19710₩30300
Market Cap
394.29B
AVG Volume
279
Trailing/Forward PE
6.46/5.61
PEG ratio
0.76
Dividend Yield
2.40%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0200B400B600B800B2016201720182019202020212022202320242025
001065.KS Revenue (KRW) by year
PeriodRevenue (KRW)
2025774.8B
2024719.38B
2023748.53B
2022684.35B
2021606.58B
2020547.34B
2019511.34B
2018537.18B
2017502.92B
2016467.47B
Net Income (KRW)
-50B-25B025B50B75B2016201720182019202020212022202320242025
001065.KS Net Income (KRW) by year
PeriodNet Income (KRW)
202561.51B
202465.04B
202337.01B
202231.89B
2021-967.85M
2020-15.24B
2019-25.28B
20188.06B
2017-742.47M
2016-10.93B
Operating Income (KRW)
-50B050B100B2016201720182019202020212022202320242025
001065.KS Operating Income (KRW) by year
PeriodOperating Income (KRW)
202594.46B
202482.73B
202399.96B
202262.96B
202131.2B
2020-1.32B
2019-19.01B
201821.58B
201721.72B
201624.54B
EBITDA (KRW)
-50B050B100B150B2016201720182019202020212022202320242025
001065.KS EBITDA (KRW) by year
PeriodEBITDA (KRW)
2025106.62B
2024108.96B
202389.77B
202273.04B
202144.21B
202015.07B
2019-2.71B
201836.6B
201721.92B
201633.67B
Cash Flows (KRW)
-20B020B40B60B80B2016201720182019202020212022202320242025
001065.KS Cash Flows (KRW) by year
PeriodCash Flows (KRW)
202572.82B
202451.25B
202348.6B
202244.41B
20215.22B
202048.02B
201942.43B
201843.76B
201722.5B
2016-3.28B
EPS (KRW)
-2000-100001000200030002016201720182019202020212022202320242025
001065.KS EPS (KRW) by year
PeriodEPS (KRW)
20252534.75
20242644.03
20231451.86
20221384.24
2021-43.84
2020-651.39
2019-1177.71
2018245.5
2017-102.52
2016-456.37
Expenses (KRW)
0100B200B300BR&DSG&ACapex2016201720182019202020212022202320242025
001065.KS Expenses (KRW) by year
PeriodExpenses (KRW)
2025262.77B
2024257.75B
2023237.29B
2022172.83B
2021148.12B
2020130.5B
2019120.03B
2018121.17B
2017118B
2016111.54B
Cash & Debt (KRW)
0100B200B300BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
001065.KS Cash & Debt (KRW) by year
PeriodCash & Debt (KRW)
202560.25B
202432.55B
202392.84B
2022149.68B
202165.67B
202055.29B
201941.86B
201830.95B
201732.1B
201639.27B
Debt ratios
-0.500.511.5220182019202020212022202320242025
001065.KS Debt ratios by year
PeriodDebt ratios
2025-0.01
20240.19
20230.35
20220.46
20211.93
20201.79
20191.63
20181.14
Margins
0%20%40%60%2016201720182019202020212022202320242025
001065.KS Margins by year
PeriodMargins
202546.38%
202444.97%
202344.83%
202242.08%
202138.64%
202032.43%
201931.51%
201836.68%
201737.51%
201637.08%
Return on Capital
-20%-10%0%10%20%2016201720182019202020212022202320242025
001065.KS Return on Capital by year
PeriodReturn on Capital
202516.65%
202419.74%
202313.94%
202214.13%
2021-0.51%
2020-7.35%
2019-10.98%
20183.1%
2017-0.27%
2016-3.96%
Shares Outstanding
010M20M30M2016201720182019202020212022202320242025
001065.KS Shares Outstanding by year
PeriodShares Outstanding
202524.14M
202423.31M
202322.88M
202223.35M
202123.21M
202021.28M
201921.29M
201821.32M
201721.08M
201621.08M
Dividends (KRW)
02004006008002016201720182019202020212022202320242026
001065.KS Dividends (KRW) by year
PeriodDividends (KRW)
2026675
2024475
2023425
2022380.73
2021333.14
2020314.02
2019314.02
2018314.02
2017263.88
2016227.94
Book Value Per Share (KRW)
050001000015000200002016201720182019202020212022202320242025
001065.KS Book Value Per Share (KRW) by year
PeriodBook Value Per Share (KRW)
202515299.88
202414136.81
202311603.45
20229670.43
20218123.88
20209748.33
201910807.57
201812199.17
201712843.97
201613109.28
Total Assets (KRW)
0200B400B600B800B2016201720182019202020212022202320242025
001065.KS Total Assets (KRW) by year
PeriodTotal Assets (KRW)
2025605.27B
2024604.6B
2023645.04B
2022627.97B
2021633.05B
2020549.09B
2019573.21B
2018593.79B
2017630.87B
2016651.08B
PE Ratio
510152025med 10.41Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
001065.KS PE Ratio by year
PeriodPE Ratio
Sep 267.17
Sep 267.2
Sep 267.25
Aug 267.44
Aug 267.26
Aug 267.22
Aug 266.8
Jul 266.86
Jul 266.7
Jul 266.64
Jul 266.53
Jul 266.37
Jun 267.85
Jun 267.89
Jun 268.3
Jun 268.77
May 269.56
May 2610.01
May 2610.13
May 2610.17
Apr 2610.32
Apr 2610.44
Apr 2610.36
Apr 2610.48
Apr 2610.32
Mar 2610.34
Mar 2610.52
Mar 2610.77
Mar 2610.71
Feb 2611.07
Feb 2611.23
Feb 2611.34
Feb 2611.19
Jan 2610.84
Jan 2610.77
Jan 2611.13
Jan 2611.23
Jan 2611
Dec 2513.26
Dec 2513.22
Dec 2513.2
Dec 2513.15
Nov 2512.24
Nov 2512.31
Nov 2512.33
Nov 2512.02
Oct 2512.1
Oct 2512.19
Oct 2512.26
Oct 2512.31
Oct 2512.31
Sep 2510.13
Sep 2510.3
Sep 2510.45
Sep 2510.67
Aug 2510.71
Aug 2510.76
Aug 2510.95
Aug 2510.95
Aug 2511.1
Jul 2511.08
Jul 2511.11
Jul 2511
Jul 2511.15
Jun 2510.37
Jun 2510.73
Jun 2510.75
Jun 2510.36
May 2510.37
May 259.93
May 2510.23
May 2510.36
May 2510.37
Apr 2510.03
Apr 259.85
Apr 259.82
Apr 259.85
Mar 259.06
Mar 259.09
Mar 259.04
Mar 259.22
Feb 259.12
Feb 259.6
Feb 259.57
Feb 259.62
Jan 259.88
Jan 259.88
Jan 259.92
Jan 259.7
Jan 259.52
Dec 2418.91
Dec 2419.43
Dec 2418.55
Dec 2418.61
Nov 2419.3
Nov 2418.97
Nov 2418.91
Nov 2420.15
Nov 2420.41
Oct 2420.08
Free Cash Flow Yield
0%5%10%15%20%med 9.14%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
001065.KS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 2612.25%
Sep 2612.19%
Sep 2612.11%
Aug 2611.8%
Aug 2612.08%
Aug 2612.16%
Aug 2612.91%
Jul 2612.79%
Jul 2613.09%
Jul 2613.22%
Jul 2613.45%
Jul 2613.78%
Jun 2615.08%
Jun 2615.01%
Jun 2614.26%
Jun 2613.5%
May 2612.39%
May 2611.83%
May 2611.69%
May 2611.65%
Apr 2611.47%
Apr 2611.34%
Apr 2611.43%
Apr 2611.3%
Apr 2611.47%
Mar 269.42%
Mar 269.26%
Mar 269.05%
Mar 269.1%
Feb 268.8%
Feb 268.68%
Feb 268.59%
Feb 268.71%
Jan 268.99%
Jan 269.05%
Jan 268.75%
Jan 268.68%
Jan 268.86%
Dec 253.7%
Dec 253.71%
Dec 253.72%
Dec 253.73%
Nov 254.01%
Nov 253.99%
Nov 253.98%
Nov 254.08%
Oct 254.05%
Oct 254.02%
Oct 254%
Oct 253.99%
Oct 253.99%
Sep 257.08%
Sep 256.96%
Sep 256.87%
Sep 256.72%
Aug 256.7%
Aug 256.66%
Aug 256.55%
Aug 256.55%
Aug 256.46%
Jul 256.47%
Jul 256.45%
Jul 256.52%
Jul 256.43%
Jun 257.6%
Jun 257.34%
Jun 257.33%
Jun 257.61%
May 257.6%
May 257.94%
May 257.7%
May 257.61%
May 257.6%
Apr 257.85%
Apr 258%
Apr 258.03%
Apr 258%
Mar 2510.05%
Mar 2510.02%
Mar 2510.07%
Mar 259.88%
Feb 259.98%
Feb 259.48%
Feb 259.51%
Feb 259.47%
Jan 259.22%
Jan 259.22%
Jan 259.17%
Jan 259.39%
Jan 259.56%
Dec 2413.91%
Dec 2413.54%
Dec 2414.18%
Dec 2414.13%
Nov 2413.63%
Nov 2413.87%
Nov 2413.91%
Nov 2413.05%
Nov 2412.89%
Oct 2413.1%
Price to Sales
0.40.60.81med 0.9Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
001065.KS Price to Sales by year
PeriodPrice to Sales
Sep 260.65
Sep 260.65
Sep 260.66
Aug 260.67
Aug 260.66
Aug 260.65
Aug 260.62
Jul 260.62
Jul 260.61
Jul 260.6
Jul 260.59
Jul 260.58
Jun 260.62
Jun 260.63
Jun 260.66
Jun 260.7
May 260.76
May 260.79
May 260.8
May 260.81
Apr 260.82
Apr 260.83
Apr 260.82
Apr 260.83
Apr 260.82
Mar 260.85
Mar 260.86
Mar 260.88
Mar 260.88
Feb 260.91
Feb 260.92
Feb 260.93
Feb 260.92
Jan 260.89
Jan 260.88
Jan 260.91
Jan 260.92
Jan 260.9
Dec 250.93
Dec 250.93
Dec 250.92
Dec 250.92
Nov 250.86
Nov 250.86
Nov 250.86
Nov 250.84
Oct 250.85
Oct 250.85
Oct 250.86
Oct 250.86
Oct 250.86
Sep 250.87
Sep 250.89
Sep 250.9
Sep 250.92
Aug 250.92
Aug 250.93
Aug 250.94
Aug 250.94
Aug 250.96
Jul 250.96
Jul 250.96
Jul 250.95
Jul 250.96
Jun 250.94
Jun 250.97
Jun 250.97
Jun 250.94
May 250.94
May 250.9
May 250.92
May 250.94
May 250.94
Apr 250.91
Apr 250.89
Apr 250.89
Apr 250.89
Mar 250.9
Mar 250.91
Mar 250.9
Mar 250.92
Feb 250.91
Feb 250.96
Feb 250.95
Feb 250.96
Jan 250.98
Jan 250.98
Jan 250.99
Jan 250.97
Jan 250.95
Dec 240.91
Dec 240.93
Dec 240.89
Dec 240.89
Nov 240.93
Nov 240.91
Nov 240.91
Nov 240.97
Nov 240.98
Oct 240.96
EV/EBITDA
46810med 6.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
001065.KS EV/EBITDA by year
PeriodEV/EBITDA
Sep 264.57
Sep 264.59
Sep 264.62
Aug 264.74
Aug 264.63
Aug 264.6
Aug 264.35
Jul 264.39
Jul 264.29
Jul 264.25
Jul 264.18
Jul 264.09
Jun 264.48
Jun 264.5
Jun 264.74
Jun 265.01
May 265.46
May 265.72
May 265.79
May 265.81
Apr 265.9
Apr 265.97
Apr 265.92
Apr 265.99
Apr 265.9
Mar 265.29
Mar 265.38
Mar 265.51
Mar 265.48
Feb 265.67
Feb 265.75
Feb 265.81
Feb 265.73
Jan 265.55
Jan 265.51
Jan 265.7
Jan 265.75
Jan 265.63
Dec 256.37
Dec 256.36
Dec 256.35
Dec 256.33
Nov 255.92
Nov 255.95
Nov 255.96
Nov 255.82
Oct 255.86
Oct 255.9
Oct 255.93
Oct 255.95
Oct 255.95
Sep 256.33
Sep 256.44
Sep 256.52
Sep 256.66
Aug 256.68
Aug 256.71
Aug 256.83
Aug 256.83
Aug 256.92
Jul 256.9
Jul 256.93
Jul 256.86
Jul 256.95
Jun 256.74
Jun 256.95
Jun 256.96
Jun 256.72
May 256.74
May 256.47
May 256.65
May 256.72
May 256.74
Apr 256.53
Apr 256.43
Apr 256.4
Apr 256.43
Mar 256.06
Mar 256.08
Mar 256.05
Mar 256.16
Feb 256.1
Feb 256.41
Feb 256.39
Feb 256.42
Jan 256.58
Jan 256.58
Jan 256.61
Jan 256.47
Jan 256.36
Dec 249.32
Dec 249.55
Dec 249.16
Dec 249.19
Nov 249.49
Nov 249.35
Nov 249.32
Nov 249.87
Nov 249.99
Oct 249.84
Price/Operating Cashflow
57.51012.515med 7.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
001065.KS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 266.01
Sep 266.04
Sep 266.08
Aug 266.24
Aug 266.09
Aug 266.05
Aug 265.7
Jul 265.75
Jul 265.62
Jul 265.57
Jul 265.47
Jul 265.34
Jun 265.01
Jun 265.03
Jun 265.3
Jun 265.6
May 266.1
May 266.39
May 266.46
May 266.49
Apr 266.59
Apr 266.66
Apr 266.61
Apr 266.69
Apr 266.59
Mar 267.4
Mar 267.52
Mar 267.7
Mar 267.66
Feb 267.92
Feb 268.03
Feb 268.11
Feb 268
Jan 267.75
Jan 267.7
Jan 267.96
Jan 268.03
Jan 267.86
Dec 2513.35
Dec 2513.3
Dec 2513.28
Dec 2513.24
Nov 2512.32
Nov 2512.38
Nov 2512.41
Nov 2512.09
Oct 2512.18
Oct 2512.27
Oct 2512.34
Oct 2512.38
Oct 2512.38
Sep 258.73
Sep 258.88
Sep 259.01
Sep 259.2
Aug 259.23
Aug 259.28
Aug 259.44
Aug 259.44
Aug 259.57
Jul 259.55
Jul 259.58
Jul 259.49
Jul 259.62
Jun 258.5
Jun 258.79
Jun 258.81
Jun 258.48
May 258.5
May 258.13
May 258.38
May 258.48
May 258.5
Apr 258.22
Apr 258.07
Apr 258.04
Apr 258.07
Mar 256.99
Mar 257.02
Mar 256.98
Mar 257.12
Feb 257.04
Feb 257.41
Feb 257.39
Feb 257.43
Jan 257.63
Jan 257.63
Jan 257.66
Jan 257.49
Jan 257.35
Dec 245.61
Dec 245.76
Dec 245.5
Dec 245.52
Nov 245.72
Nov 245.63
Nov 245.61
Nov 245.98
Nov 246.05
Oct 245.96
Price to Book
11.522.53med 1.98Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
001065.KS Price to Book by year
PeriodPrice to Book
Sep 261.34
Sep 261.35
Sep 261.36
Aug 261.39
Aug 261.36
Aug 261.35
Aug 261.27
Jul 261.29
Jul 261.26
Jul 261.24
Jul 261.22
Jul 261.19
Jun 261.31
Jun 261.31
Jun 261.38
Jun 261.46
May 261.59
May 261.67
May 261.69
May 261.69
Apr 261.72
Apr 261.74
Apr 261.73
Apr 261.75
Apr 261.72
Mar 261.83
Mar 261.86
Mar 261.91
Mar 261.9
Feb 261.96
Feb 261.99
Feb 262.01
Feb 261.98
Jan 261.92
Jan 261.91
Jan 261.97
Jan 261.99
Jan 261.95
Dec 252.14
Dec 252.13
Dec 252.12
Dec 252.12
Nov 251.97
Nov 251.98
Nov 251.98
Nov 251.93
Oct 251.95
Oct 251.96
Oct 251.97
Oct 251.98
Oct 251.98
Sep 251.91
Sep 251.94
Sep 251.97
Sep 252.01
Aug 252.02
Aug 252.03
Aug 252.06
Aug 252.06
Aug 252.09
Jul 252.09
Jul 252.1
Jul 252.07
Jul 252.1
Jun 252.05
Jun 252.12
Jun 252.12
Jun 252.04
May 252.05
May 251.96
May 252.02
May 252.04
May 252.05
Apr 251.98
Apr 251.95
Apr 251.94
Apr 251.95
Mar 252.19
Mar 252.2
Mar 252.18
Mar 252.23
Feb 252.2
Feb 252.32
Feb 252.31
Feb 252.32
Jan 252.39
Jan 252.39
Jan 252.4
Jan 252.34
Jan 252.3
Dec 242.38
Dec 242.44
Dec 242.33
Dec 242.34
Nov 242.43
Nov 242.39
Nov 242.38
Nov 242.53
Nov 242.57
Oct 242.53
JW Pharmaceutical Corporation
001065.KS
Stockpicker

Video analysis: 001065.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.